[Federal Register Volume 77, Number 194 (Friday, October 5, 2012)]
[Page 61007]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-24476]



Food and Drug Administration

[Docket No. FDA-2012-N-0001]

Request for Nominations for Voting Members on a Public Advisory 
Committee; Tobacco Products Scientific Advisory Committee

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.


SUMMARY: The Food and Drug Administration (FDA) is requesting 
nominations for voting members to serve on the Tobacco Products 
Scientific Advisory Committee, Office of Science, Center for Tobacco 
    FDA seeks to include the views of women and men, members of all 
racial and ethnic groups, and individuals with and without disabilities 
on its advisory committees and, therefore encourages nominations of 
appropriately qualified candidates from these groups.

DATES: Nominations received on or before December 4, 2012, will be 
given first consideration for membership on the Tobacco Products 
Scientific Advisory Committee. Nominations received after December 4, 
2012, will be considered for nomination to the committee as later 
vacancies occur.

ADDRESSES: All nominations for membership should be sent electronically 
to [email protected] or by mail to Advisory Committee Oversight and 
Management Staff, Food and Drug Administration, 10903 New Hampshire 
Ave., Bldg. 32, Rm. 5103, Silver Spring, MD 20993-0002.

FOR FURTHER INFORMATION CONTACT: Regarding all nomination questions for 
membership, the primary contact is: Caryn Cohen, Center for Tobacco 
Products, Food and Drug Administration, 9200 Corporate Blvd., 
Rockville, MD 20850, 1-877-287-1373 (choose Option 4), FAX: 240-276-
3655, [email protected].
    Information about becoming a member on an FDA advisory committee 
can also be obtained by visiting FDA's Web site at http://www.fda.gov/AdvisoryCommittees/default.htm.

SUPPLEMENTARY INFORMATION: FDA is requesting nomination for voting 
members on the Tobacco Products Scientific Advisory Committee. 
Elsewhere in this issue of the Federal Register, FDA is publishing a 
separate document announcing the Request for Notification for Nonvoting 
Members on the Tobacco Products Scientific Advisory Committee.

I. General Description of the Committee Duties

    The Tobacco Products Scientific Advisory Committee advises the 
Commissioner of Food and Drugs (the Commissioner) or designee in 
discharging responsibilities as they relate to the regulation of 
tobacco products. The Committee reviews and evaluates safety, 
dependence, and health issues relating to tobacco products and provides 
appropriate advice, information and recommendations to the 

II. Criteria for Voting Members

    The Committee shall consist of 12 members including the Chair. 
Members and the Chair are selected by the Commissioner or designee from 
among individuals knowledgeable in the fields of medicine, medical 
ethics, science, or technology involving the manufacture, evaluation, 
or use of tobacco products. Members will be invited to serve for 
overlapping terms of up to 4 years. Almost all non-Federal members of 
this committee serve as Special Government Employees. The Committee 
shall include nine technically qualified voting members, selected by 
the Commissioner or designee. The nine voting members shall be 
physicians, dentists, scientists, or health care professionals 
practicing in the area of oncology, pulmonology, cardiology, 
toxicology, pharmacology, addiction, or any other relevant specialty.
    In addition to the voting members, the committee shall include 
three nonvoting members who are identified with industry interests. 
These members shall include one representative of the tobacco 
manufacturing industry, one representative of the interests of tobacco 
growers, and one representative of the interests of the small business 
tobacco manufacturing industry.

III. Nomination Procedures

    Any interested person may nominate one or more qualified 
individuals for membership on the advisory committee. Self-nominations 
are also accepted. Nominations must include a current, complete resume 
or curriculum vitae for each nominee, including current business 
address and/or home address, telephone number, and email address if 
available. Nominations must also specify the advisory committee for 
which the nominee is recommended. Nominations must also acknowledge 
that the nominee is aware of the nomination unless self-nominated. FDA 
will ask potential candidates to provide detailed information 
concerning such matters related to financial holdings, employment, and 
research grants and/or contracts to permit evaluation of possible 
sources of conflicts of interest.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

    Dated: September 24, 2012.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2012-24476 Filed 10-3-12; 8:45 am]